Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects

OBJECTIVE: An exploratory phase II, multicenter, open-label, clinical trial (NCT03687632) was conducted to evaluate the safety and effectiveness in treating persistent corneal epithelial defects (PEDs) with ST266, a proprietary novel multi-cytokine platform biologic solution secreted by cultured Amn...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeng, Bennie H., Hamrah, Pedram, Kirshner, Ziv Z., Mendez, Benjamin C., Wessel, Howard C., Brown, Larry R., Steed, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742509/
https://www.ncbi.nlm.nih.gov/pubmed/34994777
http://dx.doi.org/10.1167/tvst.11.1.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742509/
https://www.ncbi.nlm.nih.gov/pubmed/34994777
http://dx.doi.org/10.1167/tvst.11.1.8

Ejemplares similares